pfizer inc (PFE:New York)
Mikael Dolsten Ph.D.
President of Worldwide Research and Development, Pfizer Inc.
|Age||Total Calculated Compensation||This person is connected to 35 board members in 1 different organizations across 3 different industries.|
See Board Relationships
As of Fiscal Year 2012
Prof. Mikael Dolste, Ph.D. has been the President of Worldwide Research and Development of Pfizer Inc. since December 2010. Prof. Dolsten is a Partner at OrbiMed Advisors, L.L.C. Prof. Dolsten serves as Head of Corporate Division Pharma Research/Discovery at Boehringer Ingelheim with responsibility for approximately 1400 discovery scientists and world-wide research in respiratory, immunology/inflammation, metabolic disease, CNS/pain, oncology and cardiovascular therapies. ...
Corporate Headquarters*235 East 42nd Street
New York, New York 10017-5755
Board Members Memberships*
Skåne University Hospital
|Robert A. McDonald||Chairman, Chief Executive Officer, President and Member of Proxy Committee|
Procter & Gamble Co.
|Alex Gorsky||Chairman, Chief Executive Officer, Chairman of Executive Committee and Chairman of Finance Committee|
Johnson & Johnson
|Joseph Jimenez MBA||Chief Executive Officer and Member of Executive Committee|
|Christopher A. Viehbacher||Chief Executive Officer, Director and Member of Strategy Committee|
|Severin Schwan||Chief Executive Officer and Director|
Roche Holding AG
|SFr.6.5M||Compensation as of Fiscal Year 2012.|
Post a JobJobs
- New York, NY | PfizerPosted: Mar 18
- New York, NY | PfizerPosted: Apr 24
- Cambridge, MA | PfizerPosted: Feb 22
- Madison, NJ | PfizerPosted: Apr 17